These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21953546)

  • 21. Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions.
    Glunde K; Ackerstaff E; Mori N; Jacobs MA; Bhujwalla ZM
    Mol Pharm; 2006; 3(5):496-506. PubMed ID: 17009848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis.
    Katz-Brull R; Seger D; Rivenson-Segal D; Rushkin E; Degani H
    Cancer Res; 2002 Apr; 62(7):1966-70. PubMed ID: 11929812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting choline phospholipid metabolism: GDPD5 and GDPD6 silencing decrease breast cancer cell proliferation, migration, and invasion.
    Cao MD; Cheng M; Rizwan A; Jiang L; Krishnamachary B; Bhujwalla ZM; Bathen TF; Glunde K
    NMR Biomed; 2016 Aug; 29(8):1098-107. PubMed ID: 27356959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone deacetylase inhibition increases levels of choline kinase α and phosphocholine facilitating noninvasive imaging in human cancers.
    Beloueche-Babari M; Arunan V; Troy H; te Poele RH; te Fong AC; Jackson LE; Payne GS; Griffiths JR; Judson IR; Workman P; Leach MO; Chung YL
    Cancer Res; 2012 Feb; 72(4):990-1000. PubMed ID: 22194463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells.
    Pan MR; Hou MF; Chang HC; Hung WC
    J Biol Chem; 2008 Apr; 283(17):11155-63. PubMed ID: 18319253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer cell cyclooxygenase-2 expression alters extracellular matrix structure and function and numbers of cancer associated fibroblasts.
    Krishnamachary B; Stasinopoulos I; Kakkad S; Penet MF; Jacob D; Wildes F; Mironchik Y; Pathak AP; Solaiyappan M; Bhujwalla ZM
    Oncotarget; 2017 Mar; 8(11):17981-17994. PubMed ID: 28152501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31) P MRS.
    Wijnen JP; Jiang L; Greenwood TR; Cheng M; Döpkens M; Cao MD; Bhujwalla ZM; Krishnamachary B; Klomp DW; Glunde K
    NMR Biomed; 2014 Jun; 27(6):692-9. PubMed ID: 24764256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The malignant phenotype of breast cancer cells is reduced by COX-2 silencing.
    Stasinopoulos I; Mori N; Bhujwalla ZM
    Neoplasia; 2008 Nov; 10(11):1163-9. PubMed ID: 18953425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies.
    Eliyahu G; Kreizman T; Degani H
    Int J Cancer; 2007 Apr; 120(8):1721-30. PubMed ID: 17236204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of indomethacin-induced alterations in the choline phospholipid metabolism of breast cancer cells.
    Glunde K; Jie C; Bhujwalla ZM
    Neoplasia; 2006 Sep; 8(9):758-71. PubMed ID: 16984733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interplay of choline metabolites and genes in patient-derived breast cancer xenografts.
    Grinde MT; Skrbo N; Moestue SA; Rødland EA; Borgan E; Kristian A; Sitter B; Bathen TF; Børresen-Dale AL; Mælandsmo GM; Engebraaten O; Sørlie T; Marangoni E; Gribbestad IS
    Breast Cancer Res; 2014 Jan; 16(1):R5. PubMed ID: 24447408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells.
    Kang JH; Song KH; Jeong KC; Kim S; Choi C; Lee CH; Oh SH
    BMC Cancer; 2011 Aug; 11():334. PubMed ID: 21813027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of the S1P
    Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
    Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolism.
    Teichert F; Verschoyle RD; Greaves P; Edwards RE; Teahan O; Jones DJ; Wilson ID; Farmer PB; Steward WP; Gant TW; Gescher AJ; Keun HC
    Prostate; 2008 Jul; 68(10):1035-47. PubMed ID: 18459103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COX-2 dependent regulation of mechanotransduction in human breast cancer cells.
    Yoon AR; Stasinopoulos I; Kim JH; Yong HM; Kilic O; Wirtz D; Bhujwalla ZM; An SS
    Cancer Biol Ther; 2015; 16(3):430-7. PubMed ID: 25701047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling.
    Yalcin A; Clem B; Makoni S; Clem A; Nelson K; Thornburg J; Siow D; Lane AN; Brock SE; Goswami U; Eaton JW; Telang S; Chesney J
    Oncogene; 2010 Jan; 29(1):139-49. PubMed ID: 19855431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of p53 function in colon cancer cells results in increased phosphocholine and total choline.
    Mori N; Delsite R; Natarajan K; Kulawiec M; Bhujwalla ZM; Singh KK
    Mol Imaging; 2004 Oct; 3(4):319-23. PubMed ID: 15802048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pro-migratory actions of the prostacyclin receptor in human breast cancer cells that over-express cyclooxygenase-2.
    Allison SE; Petrovic N; Mackenzie PI; Murray M
    Biochem Pharmacol; 2015 Aug; 96(4):306-14. PubMed ID: 26067757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of choline kinase by extracellular Ca2+ is Ca(2+)-sensing receptor, Galpha12 and Rho-dependent in breast cancer cells.
    Huang C; Hydo LM; Liu S; Miller RT
    Cell Signal; 2009 Dec; 21(12):1894-900. PubMed ID: 19716891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness.
    Bocca C; Ievolella M; Autelli R; Motta M; Mosso L; Torchio B; Bozzo F; Cannito S; Paternostro C; Colombatto S; Parola M; Miglietta A
    Expert Opin Ther Targets; 2014 Feb; 18(2):121-35. PubMed ID: 24325753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.